The imbalance in RA signaling may be associated with occurrence of oral and pharyngeal cancer, and the low expression of RARs, lower levels of cellular RA, reduced transcription of RA-metabolizing enzyme CYP26A1, and changes in RA metabolism may be involved in the carcinogenic pathway [15]. This evidence concerns the gene CYP26A1 and pharynx cancer.